GAS5 and neoplasm: While GAS5 predominated in degenerating tumor cells in all patients, it can be speculated that patients who responded to chemotherapeutic intervention demonstrated even further elevated levels of this tumor suppressor than non-responders, perhaps influencing an extension in overall survival.